Emergent Biosolutions
EBS
EBS
156 hedge funds and large institutions have $332M invested in Emergent Biosolutions in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 140 → 156 (+16)
5.47% more ownership
Funds ownership: 58.66% → 64.13% (+5.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
156
Holding in Top 10
2
Calls
$4.86M
Puts
$2.25M
Top Buyers
| 1 | +$6.42M | |
| 2 | +$6.11M | |
| 3 | +$4.98M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.57M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.55M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$8.93M | |
| 3 | -$3.71M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.88M |
| 5 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
-$1.67M |